Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 28 studies | 30% ± 10% | |
fibroblast | 23 studies | 26% ± 7% | |
astrocyte | 19 studies | 43% ± 16% | |
oligodendrocyte precursor cell | 15 studies | 40% ± 17% | |
macrophage | 14 studies | 28% ± 9% | |
smooth muscle cell | 13 studies | 23% ± 7% | |
oligodendrocyte | 13 studies | 29% ± 9% | |
pericyte | 11 studies | 23% ± 5% | |
microglial cell | 11 studies | 35% ± 12% | |
basal cell | 9 studies | 27% ± 18% | |
epithelial cell | 8 studies | 37% ± 18% | |
endothelial cell of artery | 8 studies | 25% ± 9% | |
adipocyte | 7 studies | 24% ± 6% | |
endothelial cell of lymphatic vessel | 6 studies | 33% ± 10% | |
myeloid cell | 6 studies | 22% ± 4% | |
retinal cone cell | 6 studies | 26% ± 9% | |
vein endothelial cell | 6 studies | 31% ± 16% | |
Mueller cell | 6 studies | 35% ± 14% | |
type I pneumocyte | 6 studies | 21% ± 6% | |
connective tissue cell | 6 studies | 27% ± 9% | |
GABAergic neuron | 5 studies | 35% ± 12% | |
retinal bipolar neuron | 5 studies | 31% ± 6% | |
retinal pigment epithelial cell | 5 studies | 77% ± 12% | |
cardiac muscle cell | 5 studies | 39% ± 12% | |
retinal rod cell | 5 studies | 25% ± 6% | |
capillary endothelial cell | 5 studies | 26% ± 9% | |
monocyte | 4 studies | 17% ± 2% | |
club cell | 4 studies | 17% ± 1% | |
ciliated cell | 4 studies | 29% ± 10% | |
lymphocyte | 4 studies | 20% ± 4% | |
myofibroblast cell | 4 studies | 26% ± 6% | |
endothelial cell of vascular tree | 4 studies | 31% ± 18% | |
luminal cell of prostate epithelium | 4 studies | 21% ± 4% | |
pancreatic A cell | 3 studies | 29% ± 7% | |
glial cell | 3 studies | 22% ± 1% | |
mononuclear phagocyte | 3 studies | 21% ± 2% | |
ON-bipolar cell | 3 studies | 38% ± 14% | |
rod bipolar cell | 3 studies | 64% ± 12% | |
luminal hormone-sensing cell of mammary gland | 3 studies | 26% ± 11% | |
muscle cell | 3 studies | 30% ± 15% | |
glutamatergic neuron | 3 studies | 39% ± 4% | |
pancreatic ductal cell | 3 studies | 48% ± 23% | |
adventitial cell | 3 studies | 21% ± 6% | |
alveolar macrophage | 3 studies | 27% ± 8% | |
granule cell | 3 studies | 17% ± 1% | |
interneuron | 3 studies | 34% ± 9% | |
podocyte | 3 studies | 73% ± 4% | |
renal alpha-intercalated cell | 3 studies | 32% ± 6% | |
renal principal cell | 3 studies | 28% ± 8% | |
secretory cell | 3 studies | 18% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 99% | 5721.62 | 1437 / 1445 | 100% | 109.85 | 183 / 183 |
brain | 99% | 5502.18 | 2627 / 2642 | 99% | 114.85 | 701 / 705 |
lung | 100% | 8497.16 | 576 / 578 | 99% | 88.62 | 1138 / 1155 |
breast | 100% | 6280.90 | 459 / 459 | 98% | 82.43 | 1092 / 1118 |
thymus | 100% | 8284.45 | 653 / 653 | 96% | 104.83 | 583 / 605 |
kidney | 100% | 7529.18 | 89 / 89 | 96% | 103.96 | 861 / 901 |
prostate | 100% | 5093.48 | 244 / 245 | 96% | 54.65 | 481 / 502 |
pancreas | 98% | 3452.80 | 321 / 328 | 97% | 89.00 | 173 / 178 |
uterus | 100% | 8580.10 | 170 / 170 | 94% | 57.29 | 432 / 459 |
stomach | 99% | 4807.28 | 356 / 359 | 93% | 53.04 | 266 / 286 |
bladder | 100% | 6224.81 | 21 / 21 | 89% | 49.31 | 448 / 504 |
intestine | 100% | 5149.09 | 964 / 966 | 89% | 44.31 | 468 / 527 |
ovary | 100% | 8883.26 | 180 / 180 | 88% | 39.97 | 378 / 430 |
skin | 100% | 8039.11 | 1804 / 1809 | 85% | 52.87 | 401 / 472 |
adrenal gland | 100% | 8090.86 | 258 / 258 | 75% | 30.30 | 172 / 230 |
liver | 54% | 1308.53 | 121 / 226 | 55% | 29.16 | 225 / 406 |
adipose | 100% | 7171.55 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 13711.62 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 3564.54 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 21.64 | 1 / 1 |
tonsil | 0% | 0 | 0 / 0 | 98% | 90.13 | 44 / 45 |
muscle | 97% | 3151.33 | 782 / 803 | 0% | 0 | 0 / 0 |
heart | 96% | 8699.71 | 825 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 48% | 11.73 | 14 / 29 |
eye | 0% | 0 | 0 / 0 | 41% | 12.61 | 33 / 80 |
peripheral blood | 17% | 358.37 | 158 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0001525 | Biological process | angiogenesis |
GO_0031589 | Biological process | cell-substrate adhesion |
GO_2000536 | Biological process | negative regulation of entry of bacterium into host cell |
GO_0033627 | Biological process | cell adhesion mediated by integrin |
GO_0033690 | Biological process | positive regulation of osteoblast proliferation |
GO_0007160 | Biological process | cell-matrix adhesion |
GO_0035987 | Biological process | endodermal cell differentiation |
GO_0070371 | Biological process | ERK1 and ERK2 cascade |
GO_0001570 | Biological process | vasculogenesis |
GO_1902533 | Biological process | positive regulation of intracellular signal transduction |
GO_0007155 | Biological process | cell adhesion |
GO_0045785 | Biological process | positive regulation of cell adhesion |
GO_0034113 | Biological process | heterotypic cell-cell adhesion |
GO_1905598 | Biological process | negative regulation of low-density lipoprotein receptor activity |
GO_0050919 | Biological process | negative chemotaxis |
GO_0010745 | Biological process | negative regulation of macrophage derived foam cell differentiation |
GO_0032369 | Biological process | negative regulation of lipid transport |
GO_0046718 | Biological process | symbiont entry into host cell |
GO_0007229 | Biological process | integrin-mediated signaling pathway |
GO_0043277 | Biological process | apoptotic cell clearance |
GO_0030335 | Biological process | positive regulation of cell migration |
GO_0007204 | Biological process | positive regulation of cytosolic calcium ion concentration |
GO_0038027 | Biological process | apolipoprotein A-I-mediated signaling pathway |
GO_0034446 | Biological process | substrate adhesion-dependent cell spreading |
GO_0097192 | Biological process | extrinsic apoptotic signaling pathway in absence of ligand |
GO_0051057 | Biological process | positive regulation of small GTPase mediated signal transduction |
GO_0085017 | Biological process | entry into host cell by a symbiont-containing vacuole |
GO_2001237 | Biological process | negative regulation of extrinsic apoptotic signaling pathway |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0050764 | Biological process | regulation of phagocytosis |
GO_0050748 | Biological process | negative regulation of lipoprotein metabolic process |
GO_0010888 | Biological process | negative regulation of lipid storage |
GO_0098609 | Biological process | cell-cell adhesion |
GO_0035313 | Biological process | wound healing, spreading of epidermal cells |
GO_0016477 | Biological process | cell migration |
GO_0070588 | Biological process | calcium ion transmembrane transport |
GO_0071604 | Biological process | transforming growth factor beta production |
GO_0032587 | Cellular component | ruffle membrane |
GO_0034683 | Cellular component | integrin alphav-beta3 complex |
GO_0009897 | Cellular component | external side of plasma membrane |
GO_0035579 | Cellular component | specific granule membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0031528 | Cellular component | microvillus membrane |
GO_0008305 | Cellular component | integrin complex |
GO_0070062 | Cellular component | extracellular exosome |
GO_0035866 | Cellular component | alphav-beta3 integrin-PKCalpha complex |
GO_0005925 | Cellular component | focal adhesion |
GO_0031527 | Cellular component | filopodium membrane |
GO_0009986 | Cellular component | cell surface |
GO_0034686 | Cellular component | integrin alphav-beta8 complex |
GO_0031258 | Cellular component | lamellipodium membrane |
GO_0005829 | Cellular component | cytosol |
GO_0045335 | Cellular component | phagocytic vesicle |
GO_0035867 | Cellular component | alphav-beta3 integrin-IGF-1-IGF1R complex |
GO_0034682 | Cellular component | integrin alphav-beta1 complex |
GO_0034684 | Cellular component | integrin alphav-beta5 complex |
GO_0035868 | Cellular component | alphav-beta3 integrin-HMGB1 complex |
GO_0034685 | Cellular component | integrin alphav-beta6 complex |
GO_0005080 | Molecular function | protein kinase C binding |
GO_1990430 | Molecular function | extracellular matrix protein binding |
GO_0015026 | Molecular function | coreceptor activity |
GO_0019960 | Molecular function | C-X3-C chemokine binding |
GO_0001968 | Molecular function | fibronectin binding |
GO_0001618 | Molecular function | virus receptor activity |
GO_0031994 | Molecular function | insulin-like growth factor I binding |
GO_0005178 | Molecular function | integrin binding |
GO_0002020 | Molecular function | protease binding |
GO_0050431 | Molecular function | transforming growth factor beta binding |
GO_0005245 | Molecular function | voltage-gated calcium channel activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0001846 | Molecular function | opsonin binding |
GO_0050840 | Molecular function | extracellular matrix binding |
GO_0038132 | Molecular function | neuregulin binding |
GO_0017134 | Molecular function | fibroblast growth factor binding |
GO_0005515 | Molecular function | protein binding |
Gene name | ITGAV |
Protein name | Integrin alpha-V (Vitronectin receptor) (Vitronectin receptor subunit alpha) (CD antigen CD51) [Cleaved into: Integrin alpha-V heavy chain; Integrin alpha-V light chain] ITGAV protein Integrin, alpha V Integrin subunit alpha V |
Synonyms | VTNR VNRA MSK8 |
Description | FUNCTION: The alpha-V (ITGAV) integrins are receptors for vitronectin, cytotactin, fibronectin, fibrinogen, laminin, matrix metalloproteinase-2, osteopontin, osteomodulin, prothrombin, thrombospondin and vWF. They recognize the sequence R-G-D in a wide array of ligands. ITGAV:ITGB3 binds to fractalkine (CX3CL1) and may act as its coreceptor in CX3CR1-dependent fractalkine signaling . ITGAV:ITGB3 binds to NRG1 (via EGF domain) and this binding is essential for NRG1-ERBB signaling . ITGAV:ITGB3 binds to FGF1 and this binding is essential for FGF1 signaling . ITGAV:ITGB3 binds to FGF2 and this binding is essential for FGF2 signaling . ITGAV:ITGB3 binds to IGF1 and this binding is essential for IGF1 signaling . ITGAV:ITGB3 binds to IGF2 and this binding is essential for IGF2 signaling . ITGAV:ITGB3 binds to IL1B and this binding is essential for IL1B signaling . ITGAV:ITGB3 binds to PLA2G2A via a site (site 2) which is distinct from the classical ligand-binding site (site 1) and this induces integrin conformational changes and enhanced ligand binding to site 1 . ITGAV:ITGB3 and ITGAV:ITGB6 act as receptors for fibrillin-1 (FBN1) and mediate R-G-D-dependent cell adhesion to FBN1 . Integrin alpha-V/beta-6 or alpha-V/beta-8 (ITGAV:ITGB6 or ITGAV:ITGB8) mediates R-G-D-dependent release of transforming growth factor beta-1 (TGF-beta-1) from regulatory Latency-associated peptide (LAP), thereby playing a key role in TGF-beta-1 activation . ITGAV:ITGB3 acts as a receptor for CD40LG . ITGAV:ITGB3 acts as a receptor for IBSP and promotes cell adhesion and migration to IBSP . .; FUNCTION: (Microbial infection) Integrin ITGAV:ITGB5 acts as a receptor for Adenovirus type C. .; FUNCTION: (Microbial infection) Integrin ITGAV:ITGB5 and ITGAV:ITGB3 act as receptors for Coxsackievirus A9 and B1. .; FUNCTION: (Microbial infection) Integrin ITGAV:ITGB3 acts as a receptor for Herpes virus 8/HHV-8. .; FUNCTION: (Microbial infection) Integrin ITGAV:ITGB6 acts as a receptor for herpes simplex 1/HHV-1. .; FUNCTION: (Microbial infection) Integrin ITGAV:ITGB3 acts as a receptor for Human parechovirus 1. .; FUNCTION: (Microbial infection) Integrin ITGAV:ITGB3 acts as a receptor for West nile virus. .; FUNCTION: (Microbial infection) In case of HIV-1 infection, the interaction with extracellular viral Tat protein seems to enhance angiogenesis in Kaposi's sarcoma lesions. . |
Accessions | ENST00000696914.1 ENST00000696907.1 A0A8V8TKH9 ENST00000261023.8 [P06756-1] A5YM53 ENST00000696937.1 ENST00000696906.1 ENST00000696912.1 A0A8V8TLN8 ENST00000696909.1 ENST00000433736.6 [P06756-3] ENST00000696908.1 ENST00000696910.1 A0A8V8TKI2 L7RXH0 A0A8V8TKF7 P06756 ENST00000696911.1 A0A8V8TKU8 A0A8V8TKG0 A0A8V8TLW4 ENST00000696913.1 H7BZG1 ENST00000374907.7 [P06756-2] ENST00000430709.1 A0A8V8TLP3 A0A8V8TKT8 A0A8V8TLW9 |